| Company Name: |
Nextpeptide Inc |
| Tel: |
+86-0571-81612335 +8613336028439 |
| Email: |
sales@nextpeptide.com |
|
| | PEG3-bis-(ethyl phosphonate) Basic information |
| Product Name: | PEG3-bis-(ethyl phosphonate) | | Synonyms: | PEG3-bis-(ethyl phosphonate);Phosphonic acid, P,P'-[oxybis(2,1-ethanediyloxy-2,1-ethanediyl)]bis-, P,P,P',P'-tetraethyl ester;Diethyl-[oxybis(2,1-ethanediyloxy-2,1-ethanediyl)]bis-phosphonate;P,P,P′,P′-Tetraethyl P,P′-[oxybis(2,1-ethanediyloxy-2,1-ethanediyl)]bis[phosphon… | | CAS: | 160625-24-1 | | MF: | C16H36O9P2 | | MW: | 434.4 | | EINECS: | | | Product Categories: | | | Mol File: | 160625-24-1.mol |  |
| | PEG3-bis-(ethyl phosphonate) Chemical Properties |
| Boiling point | 510.5±45.0 °C(Predicted) | | density | 1.126±0.06 g/cm3(Predicted) |
| | PEG3-bis-(ethyl phosphonate) Usage And Synthesis |
| Description | PEG3-bis-(ethyl phosphonate) is a PEG linker with two ethyl phosphonate end groups. The hydrophilic PEG linker increases the water solubility of the compound in aqueous media. | | Uses | PEG3-bis-(ethyl phosphonate) is a PEG-based PROTAC linker that can be used in the synthesis of PROTACs[1]. | | IC 50 | PEGs | | References | [1] An S, et al. Small-molecule PROTACs: An emerging and promising approach for the development of targeted therapy drugs. EBioMedicine. 2018 Oct;36:553-562 DOI:10.1016/j.ebiom.2018.09.005 |
| | PEG3-bis-(ethyl phosphonate) Preparation Products And Raw materials |
|